43
Participants
Start Date
June 29, 2021
Primary Completion Date
October 9, 2023
Study Completion Date
October 9, 2023
ESO-101
Daily administration in the evening at bedtime for 28 days
Placebo
Daily administration in the evening at bedtime for 28 days
Facharztzentrum Eppendorf, Hamburg
Universitätsklinikum Leipzig AöR, Leipzig
Otto-von-Guericke-Universität Medizinische Fakultät Universitätsklinikum Magdeburg A. ö. R., Magdeburg
Klinikum rechts der Isar der TUM, München
Amsterdam University Medical Center, Amsterdam
Albert Schweitzer Ziekenhuis, Dordrecht
Centrum Medyczne Med-GASTR Sp. z o.o., Lodz
Centrum Medyczne Sonomed Sp. z o.o., Szczecin
Hospital Universitario Vall d' Hebrón, Barcelona
Hospital Universitario de La Princesa, Madrid
Hospital Universitario Fundación Jiménez Díaz, Madrid
Hospital Universitario Central De Asturias, Oviedo
Hospital de Navarra, Pamplona
Hospital General de Tomelloso, Tomelloso
Hospital Universitario Rio Hortega, Valladolid
Hospital de Viladecans, Viladecans
Universitätsspital Zürich, Zurich
Lead Sponsor
Collaborators (1)
FGK Clinical Research GmbH
INDUSTRY
FGK Representative Service B.V.
UNKNOWN
EsoCap AG
INDUSTRY